ProCE Banner Activity

Challenges in Personalizing the Management of Myelodysplastic Syndromes: Case Studies

Clinical Thought

An expert presents 3 patient cases that illustrate the challenges associated with diagnosing and personalizing treatment of MDS.

Released: November 16, 2022

Expiration: November 15, 2023

Share

Faculty

Rami Komrokji

Rami Komrokji, MD

Professor
Department of Oncologic Sciences
University of South Florida
Vice Chair
Malignant Hematology Department
Moffitt Cancer Center
Tampa, Florida

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Bristol Myers Squibb

Geron

Karyopharm Therapeutics Inc.

Novartis Pharmaceuticals Corporation

Faculty Disclosure

Primary Author

Rami Komrokji, MD

Professor
Department of Oncologic Sciences
University of South Florida
Vice Chair
Malignant Hematology Department
Moffitt Cancer Center
Tampa, Florida

Rami Komrokji, MD: consultant/advisor/speaker: AbbVie, Bristol-Myers Squibb, CTI BioPharma, Geron, Gilead Sciences, Jazz, Novartis, PharmaEssentia, Servier, Taiho, Takeda.